Form 4: Patterson Companies CEO Donald Zurbay Reports Stock Sale and Option Holdings
SEC Form 4
Donald Zurbay, President & CEO of Patterson Companies, reports the sale of 5,875 shares of common stock at $23.7144 per share and discloses holdings of common stock and employee stock options.
Summary
- Donald Zurbay, the President & CEO of Patterson Companies, filed a Form 4 detailing changes in beneficial ownership.
- On July 3, 2024, Zurbay sold 5,875 shares of common stock at a price of $23.7144 per share.
- Following the transaction, Zurbay directly owns 237,288 shares of common stock.
- Zurbay also indirectly owns 1,198 shares through an Employee Stock Ownership Plan (ESOP).
- The report details Zurbay's holdings of various employee stock options with different exercise prices and expiration dates.
- These options were granted under the Patterson Companies, Inc. Amended and Restated 2015 Omnibus Incentive Plan.
- The reported sale was executed under a Rule 10b5-1 trading plan adopted on September 25, 2023, and amended on March 12, 2024.
- Zurbay also holds 144,455 restricted stock units (RSUs) that vest between December 2024 and July 2027, contingent upon continued employment.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information. The use of a 10b5-1 plan is generally viewed neutrally to slightly positively as it indicates pre-planned, non-opportunistic trading.
Positives
- The CEO's stock transactions are being conducted under a pre-arranged 10b5-1 trading plan, which can reassure investors that the sales are not based on insider information.
Negatives
- The sale of shares by the CEO, even under a 10b5-1 plan, could be perceived negatively by some investors.
Risks
- Executive stock sales can sometimes signal a lack of confidence in the company's future performance, although this is mitigated by the use of a 10b5-1 plan.
- Fluctuations in the company's stock price could impact the value of the CEO's remaining stock options and RSUs.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options and RSUs, are standard practice across publicly traded companies, particularly in the healthcare distribution industry where Patterson Companies operates.
- Companies like Henry Schein and McKesson also utilize stock-based compensation to align executive interests with shareholder value.
- The vesting schedules and exercise prices of the options are typical for executive compensation plans.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
- The vesting of RSUs and exercisability of stock options incentivize the CEO to improve company performance, benefiting shareholders in the long run.
Key Dates
| Date | Description |
|---|---|
| 06/29/2018 | Date of inducement award of stock options granted outside the Plan. |
| 07/01/2018 | Date of stock options granted pursuant to the Plan. |
| 07/01/2019 | Date of stock options granted pursuant to the Plan. |
| 07/14/2020 | Date of stock options granted pursuant to the Plan. |
| 07/01/2021 | Date of stock options granted pursuant to the Plan. |
| 09/25/2023 | Date Reporting Person adopted Rule 10b5-1 Plan. |
| 12/05/2022 | Date of stock options granted pursuant to the Plan. |
| 07/01/2022 | Date of stock options granted pursuant to the Plan. |
| 03/12/2024 | Date Reporting Person amended Rule 10b5-1 Plan. |
| 05/04/2024 | Date shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan ('ESOP') account through. |
| 07/03/2024 | Date of the reported transaction (stock sale). |
| 07/08/2024 | Date of the report. |
| 12/05/2024 | Date 13,221 restricted stock units vest. |
| 07/01/2025 | Date 44,948 restricted stock units vest. |
| 12/05/2025 | Date 13,227 restricted stock units vest. |
| 07/01/2026 | Date 41,504 restricted stock units vest. |
| 07/01/2027 | Date 31,555 restricted stock units vest. |
| 06/29/2028 | Expiration date of stock options granted as an inducement award granted outside the Plan. |
| 07/01/2028 | Expiration date of stock options granted pursuant to the Plan. |
| 07/01/2029 | Expiration date of stock options granted pursuant to the Plan. |
| 07/14/2030 | Expiration date of stock options granted pursuant to the Plan. |
| 07/01/2031 | Expiration date of stock options granted pursuant to the Plan. |
| 07/01/2032 | Expiration date of stock options granted pursuant to the Plan. |
| 12/05/2032 | Expiration date of stock options granted pursuant to the Plan. |
| 07/01/2033 | Expiration date of stock options granted pursuant to the Plan. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.